Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors

Alessandro Di Federico, Lingzhi Hong, Arielle Elkrief, Rohit Thummalapalli, Alissa J. Cooper, Biagio Ricciuti, Subba R. Digumarthy, J.V. Alessi, Pooja Gogia, F. Pecci, Maisam Makarem, Malini Gandhi, Edoardo Garbo, Arushi Gahlot Saini, Andrea De Giglio, Valentina Favorito, Stefano Scalera, Laura Cipriani, Daniele Marinelli, Danielle Haradon, Tom C. Nguyen, Jessica Haradon, E. Voligny, V. Vaz, Francesco Gelsomino, Francesca Sperandi, Barbara Melotti, M. Ladanyi, Jian Zhang, Don L. Gibbons, John V. Heymach, Mari Nishino, James Lindsay, Scott J. Rodig, Kayla E. Pfaff, Lynette M. Sholl, Xinan Wang, B.E. Johnson, Pasi A. Jänne, Natasha Rekhtman, Marcello Maugeri‐Saccà, Rebecca S. Heist, Andrea Ardizzoni, M.M. Awad, Kathryn C. Arbour, Adam J. Schoenfeld, Natalie I. Vokes, Jia Luo